Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 13, 2020

SELL
$46.96 - $61.67 $385,118 - $505,755
-8,201 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$59.47 - $93.1 $4,519 - $7,075
76 Added 0.94%
8,201 $753,000
Q2 2019

Aug 13, 2019

BUY
$75.84 - $105.21 $33,142 - $45,976
437 Added 5.68%
8,125 $1.03 Million
Q1 2019

May 14, 2019

BUY
$64.44 - $104.11 $202,019 - $326,384
3,135 Added 68.86%
7,688 $1.21 Million
Q4 2018

Feb 14, 2019

SELL
$59.1 - $93.26 $134,275 - $211,886
-2,272 Reduced 33.29%
4,553 $452,000
Q3 2018

Nov 14, 2018

SELL
$88.86 - $117.49 $347,176 - $459,033
-3,907 Reduced 36.41%
6,825 $996,000
Q2 2018

Aug 13, 2018

BUY
$99.64 - $127.59 $603,220 - $772,429
6,054 Added 129.41%
10,732 $1.68 Million
Q1 2018

May 14, 2018

BUY
$105.8 - $150.94 $23,064 - $32,904
218 Added 4.89%
4,678 $799,000
Q4 2017

Feb 14, 2018

BUY
$81.25 - $130.7 $362,375 - $582,922
4,460
4,460 $794,000

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $677M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track L & S Advisors Inc Portfolio

Follow L & S Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of L & S Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on L & S Advisors Inc with notifications on news.